N-acetyl glucosamine improves intestinal mucosal barrier function in rat

Abstract

Our study investigated the effect of N-acetylglucosamine (GlcNAc) on the intestinal mucosal barrier function in rats. Rats were randomly assigned into normal control group, diarrhea-predominant irritable bowel syndrome (IBS-D) group and GlcNAc group. IBS-D was introduced into the IBS-D group without any treatment. The GlcNAc group were treated with GlcNAc. Microvilli and tight junctions of intestinal epithelial cells were detected. The D-lactic acid level and diamine oxidase (DAO) activity in the serum were determined. Compared with normal rats, microvilli were sparsely distributed on the intestinal epithelial cells, the tight junction gap also widened, and D-lactic acid level and DAO activity were significantly higher in the IBS-D group. After GlcNAc treatment, the microscopic structure of the intestinal mucosa became largely normal, and the level of D-lactic acid and the DAO activity were lowered. In conclusion, GlcNAc can effectively improve the intestinal mucosal barrier dysfunction, perhaps through enhancing the cellular metabolism. Article Info

Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro

“…Different mechanisms might be involved in the effect of baby M-SHIME ® supernatants on the intestinal barrier. For example, N-acetylglucosamine is one of the end products of lacto-N-biose degradation with protective effects on intestinal mucosal barrier dysfunction [60,61]. Other components of the bacterial wall such as lipopolysaccharide (LPS) from specific bacteria, pili proteins, or extracellular vesicles have regulatory effects on the intestinal homeostasis [62] and are likely to be present on the baby M-SHIME ® supernatants, with differential composition depending on the microbiota profile.…”

Performance, nutrient digestibility, and intestinal histomorphometry of broilers fed diet supplemented with chondroitin and glucosamine sulfates

“…A longer villi in the jejunum of broilers fed diet supplemented with glucosamine sulfate may be related to the ability of this nutraceutical to increase epithelial defenses, which contributes to intestinal integrity and histomorphometry, as observed in humans (Salvatore et al, 2000). According to Liu et al (2012), glucosamine may promote stabilization of intestinal mucosa barrier, which reduces penetration of intestinal endotoxins, food metabolites, and bacteria. These factors interfere with mucosal cell metabolism and intestinal histomorphometry.…”

“…Besides, glucosamine acts to prevent tissue damage by protecting the digestive mucosa (Liu et al, 2012;Ryczko et al, 2016), due to its anti-inflammatory effects (Yomogida et al, 2008;Bak et al, 2014), because it suppresses the activation of the nuclear factor Kappa B (NF-κB), an inflation marker, blocking related inflammatory responses (Bak et al, 2014). Bak et al (2014) demonstrated that glucosamine supplementation reduces inflammatory responses (IL-8, IL-1β, and TNF-α) mediated by NF-κB.…”

Gastroprotective Effects of Oral Glycosaminoglycans with Sodium Alginate in an Indomethacin-Induced Gastric Injury Model in Rats

“…The reinforcement of the mucin layer and an increase in the concentration of TJ, forming a proper barrier of intestinal epithelial cells with less permeability, could be explained by such effects and the beneficial impact of adding GAGs, provided that these improvements might not be possible solely with sodium alginate. It seems that GAGs are able to upregulate the expression and localization of TJ proteins and support the mucin layer, while improving overall barrier function [ 22 , 27 , 28 ]. Also, the intestinal microbiota plays an important role in regulating biological processes such as epithelial proliferation, mucin production, and antimicrobial compound production [ 29 ].…”